Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Injectable Drugs Market to Grow at a CAGR of 8.2% by 2021: Rising Awareness Leading to High Demand for Injectable Drugs - Research and Markets

Research and Markets
Posted on: 02 Aug 17

The "Global Injectable Drugs Market 2017-2021" report has been added to Research and Markets' offering.

The global injectable drugs market to grow at a CAGR of 8.21% during the period 2017-2021.

The report, Global Injectable Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one driver in the market is escalation in demand for self-injection devices. There has been a rise in the demand for self-injection devices in the recent years, owing to the factors such as the high demand for diabetes and other hormone replacement therapies. Diabetes is turning to be one of the most serious health concerns in the people across the world. It was estimated that, in 2015, approximately 400-425 million of the adult population were having diabetes. If this uncontrolled blood sugar stays for a longer period, it can affect the quality of life and can even lead to a slow death in longer duration. For instance, around 1.45 million people die due to diabetes each year.

Key vendors

  • AbbVie
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Sanofi

Other prominent vendors

  • Bayer
  • Bristol-Myers Squibb
  • Merck
  • Takeda Pharmaceutical
  • Teva Pharmaceutical

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Pipeline landscape

PART 07: Market segmentation by molecule type

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

For more information about this report visit https://www.researchandmarkets.com/research/dn3cn3/global_injectable

View source version on businesswire.com: http://www.businesswire.com/news/home/20170802005573/en/

Business Wire
www.businesswire.com

Last updated on: 02/08/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.